Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding EUR 0.5 Billion
Agreement builds on customer's long-term deal in new Yokohama facility for five commercial biologics programs, now allocating an additional six
Silakan masuk menggunakan akun yang telah Anda daftarken untuk mendapatkan informasi yang kami sediakan?